CpG oligonucleotides induce strong hurnoral but only weak CD4+ T cell responses to protein antigens in rhesus macaques in vivo

被引:22
作者
Hartmann, G
Marschner, A
Viveros, PR
Stahl-Hennig, C
Eisenblätter, M
Suh, YS
Endres, S
Tenner-Racz, K
Überla, K
Racz, P
Steinman, RM
Ignatius, R
机构
[1] Univ Med Berlin, Charite, Dept Med Microbiol & Infect Immunol, D-12203 Berlin, Germany
[2] Univ Munich, Dept Internal Med, Div Clin Pharmacol, D-80336 Munich, Germany
[3] German Primate Ctr, Dept Virol & Immunol, D-37077 Gottingen, Germany
[4] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany
[5] Ruhr Univ Bochum, Dept Mol & Med Virol, D-44780 Bochum, Germany
[6] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA
关键词
primates; CpG oligonucleotides; adjuvant;
D O I
10.1016/j.vaccine.2005.01.077
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oligonucleotides containing CpG motifs (CpG ODN) are strong adjuvants for humoral immune responses but data on cellular immune responses in primates are scarce. Rhesus macaque blood contained similar numbers of plasmacytoid dendritic cells and B cells, the key sensors of CpG ODN, as human blood, and these cells were activated by CpG-A and CpG-B in vitro. In vivo, both ODNs induced equal plasma levels of interferon-inducible protein 10 and similarly enhanced antibody responses following i.m. injections of the ODNs, protein antigen, and aluminium hydroxide into rhesus macaques, whereas antigen-specific CD4(+) T cell responses were only slightly increased by CpG ODN. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3310 / 3317
页数:8
相关论文
共 34 条
  • [1] Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells
    Bauer, M
    Redecke, V
    Ellwart, JW
    Scherer, B
    Kremer, JP
    Wagner, H
    Lipford, GB
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (08) : 5000 - 5007
  • [2] Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals
    Bauer, T
    Weinberger, K
    Jilg, W
    [J]. HEPATOLOGY, 2002, 35 (02) : 455 - 465
  • [3] CpG-A-induced monocyte IFN-γ-inducible protein-10 production is regulated by plasmacytoid dendritic cell-derived IFN-α
    Blackwell, SE
    Krieg, AM
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (08) : 4061 - 4068
  • [4] Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: Dependency on antigen dose and differential toll-like receptor ligation
    Boonstra, A
    Asselin-Paturel, C
    Gilliet, M
    Crain, C
    Trinchieri, G
    Liu, YJ
    O'Garra, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (01) : 101 - 109
  • [5] Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand
    Coates, PTH
    Barratt-Boyes, SM
    Zhang, LY
    Donnenberg, VS
    O'Connell, PJ
    Logar, AJ
    Duncan, FJ
    Murphey-Corb, M
    Donnenberg, AD
    Morelli, AE
    Maliszewski, CR
    Thomson, AW
    [J]. BLOOD, 2003, 102 (07) : 2513 - 2521
  • [6] COOPER CL, 2003, P 10 C RETR OPP INF
  • [7] CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans
    Davis, HL
    Suparto, I
    Weeratna, R
    Jumintarto
    Iskandriati, D
    Chamzah, S
    Ma'ruf, A
    Nente, C
    Pawitri, D
    Krieg, AM
    Heriyanto
    Smits, W
    Sajuthi, D
    [J]. VACCINE, 2000, 18 (18) : 1920 - 1924
  • [8] Toll-like receptor expression in murine DC subsets:: lack of TLR7 expression by CD8α+ DC correlates with unresponsiveness to imidazoquinolines
    Edwards, AD
    Diebold, SS
    Slack, EMC
    Tomizawa, H
    Hemmi, H
    Kaisho, T
    Akira, S
    Sousa, CR
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (04) : 827 - 833
  • [9] A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant
    Halperin, SA
    Van Nest, G
    Smith, B
    Abtahi, S
    Whiley, H
    Eiden, JJ
    [J]. VACCINE, 2003, 21 (19-20) : 2461 - 2467
  • [10] Hartemink A.E., 1999, B INT UNION SOIL SCI, V96, P16